Oleg Nodelman Biography, Career, Net Worth, and Key Insight
Oleg Nodelman’s Profile Summary
|
Company
|
EcoR1 Capital |
|---|---|
|
Position
|
Founder and Portfolio Manager at EcoR1 Capital LLC, a biotech-focused investment advisory firm. |
|
Source of wealth
|
Management and performance fees from EcoR1 Capital’s biotech investment strategies, Board membership compensation, investments in biotechnology companies |
|
Also known as
|
Oleg Nodelman is also recognized as a board member and biotech industry leader, particularly through his involvement with public biotech companies such as Prothena and AnaptysBio. |
|
Age
|
Unknown |
|
Education
|
Georgetown University – Bachelor of Science in Foreign Service, concentration in Science and Technology |
|
Citizenship
|
United States |
|
Residence
|
San Francisco, California, USA |
|
Family
|
Oleg Nodelman is married to Heather, and they met while working as translators at the 1996 Summer Olympics. Information about their children or extended family is |
|
Website, Social Media
|
https://www.ecor1cap.com/ |
Biography
Oleg Nodelman is a highly experienced biotech investor, having founded EcoR1 Capital in 2013. With over two decades in the biotech investment space, Nodelman has established deep roots within the scientific and financial communities. Before launching EcoR1 Capital, Nodelman served as a portfolio manager at BVF Partners, one of the first hedge funds dedicated to biotechnology. His investment philosophy is rooted in scientific innovation, focusing on companies at various stages of research and development. He is also recognized for his leadership roles beyond EcoR1, holding board positions at prominent biotech companies such as Prothena and AnaptysBio. Nodelman graduated from Georgetown University with a Bachelor of Science in Foreign Service, concentrating in Science and Technology. His career reflects a profound understanding of biotech and financial markets, enabling him to build EcoR1 into a highly regarded firm in the investment communityAppointed Non-Executive Non-Independent Director to Galapagos NV's Board on 2024-10-07; continues as Founder and Portfolio Manager of EcoR1 Capital.
-
How did Oleg Nodelman make money?
Oleg Nodelman makes money in the following areas:
Management and performance fees from EcoR1 Capital’s biotech investment strategies, Board membership compensation, investments in biotechnology companies
-
What is Oleg Nodelman net worth?
As of 2026, Oleg Nodelman’s net worth is estimated to be $106M.
What is Oleg Nodelman also known as?
Oleg Nodelman is actively involved in the biotech sector through his board memberships at several leading biotech companies. He currently serves on the boards of Prothena, a neuroscience-focused clinical-stage company, and AnaptysBio, which specializes in immune control mechanisms. His strategic leadership in these companies, combined with his deep expertise in biotech investing, has made him a prominent figure in advancing scientific innovation in biotechnologyProminent achievements
Oleg Nodelman founded EcoR1 Capital in 2013, which has been a leader in biotech investing, achieving a 323% increase in value within its early years. He serves on the boards of prominent biotech companies, including Prothena and AnaptysBio. He was recognized as one of the "Hedge Fund Rising Stars" in 2015, and EcoR1’s reputation in the biotech sector continues to grow.Appointed Non-Executive Non-Independent Director to Galapagos NV's Board on 2024-10-07.
What are Oleg Nodelman’s key insights?
Oleg Nodelman’s business philosophy revolves around risk management and finding companies with a margin of safety. He emphasizes the importance of intellectual property, unreleased products, or partnerships that can provide stability in the biotech industry, rather than relying solely on the science, which he believes can be unpredictable. His investment strategy at EcoR1 Capital reflects this focus on long-term value and innovation.
Personal life
Oleg Nodelman was born in Ukraine to a family with a scientific background—his mother is an immunologist and his father an engineer. His family moved to the U.S. when he was three years old, settling in San Diego. He married Heather, who was a Japanese translator at the Summer Olympics in 1996, while Nodelman was translating Russian. Details about any children are not publicly shared.
Useful insights
Decision-making and success
Making the right decisions at the right time is often what sets successful people apart. Drawing on the experience of Ray Dalio, founder of Bridgewater Associates, here are some key lessons for improving your decision-making and achieving long-term success.
-
Create a decision-making framework
Ray Dalio advocates for a clear, principles-based approach to decision-making. Establish a set of guiding principles that you consistently apply when faced with choices. This will help you stay focused and avoid emotional or impulsive decisions.
-
Embrace transparency and open feedback
Dalio’s philosophy of radical transparency is about creating an environment where honest feedback is encouraged. Whether in your career or personal life, being open to criticism and maintaining transparency will help you grow and make better decisions.
-
Prepare for risks and manager them wisely
Success isn’t just about making the right moves—it's also about managing risks effectively. Always consider worst-case scenarios and have a plan in place to navigate them. Risk management is a crucial part of any decision-making process.
Other profiles in category
Popular Financial Guides
Editors' Top Picks and Insights
Toncoin becomes Gram: Why Durov restored token's original name
Why Tether flipping Ethereum is a pivotal moment for crypto
MiCA deadline: Why crypto companies are leaving Europe
From “Holy Trinity” to WLD crash: How Arthur Hayes became a market-moving seller
The world's first trillionaire: How Musk built his fortune on electric cars, space and AI
How precious-metals mining revival is reshaping portfolios in 2026
Latest Financial News
Global markets rally as Iran deal progress eases oil concerns
U.S. senators press Trump to end Russian oil sanctions waiver